- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04652674
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic
December 22, 2022 updated by: Karen Zaghiyan, Cedars-Sinai Medical Center
The purpose of this clinical study is to evaluate whether remote video/audio postoperative visits (telemedicine visits) affects patient satisfaction compared to in-person visits during the COVID-19 pandemic.
If the primary objective of the study is achieved, it would allow better understanding of how telemedicine can be integrated into modern surgical practice to take care of postoperative patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Cedars Sinai Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 96 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients over 18 years of age inclusive at the time of the study who underwent colorectal surgery and are presenting for their first postoperative visit
- Patients with a computer or phone device with video and audio capabilities
Exclusion Criteria:
- Children <18 years of age
- Patients with mental disability
- Patients without a computer or phone device with video and audio capabilities
- Patients who require physical intervention during their first postoperative visit (e.g. drain removal, suture removal, staple removal)
- Patients who are readmitted to the hospital prior to their first postoperative visit will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group I
Patients who will undergo telemedicine visit approximately 1 week postoperatively, then an in-person clinic visit approximately 4 weeks postoperatively
|
A postoperative visit with the patient's surgeon conducted remotely via audio/video smartphone app
Other Names:
|
|
Active Comparator: Group II
Patients who will undergo in-person clinic visit approximately 1 week postoperatively, then a telemedicine visit approximately 4 weeks postoperatively
|
A standard-of-care in-person postoperatively visit with the patient's surgeon
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction
Time Frame: 7 to 14 days postoperatively
|
Patient satisfaction score measured by electronic survey sent to all participating patients after their first postoperative visit
|
7 to 14 days postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-reported rating of safety
Time Frame: 7 to 14 days postoperatively
|
Patient-reported sense of safety score rated from 1 to 5 with higher scores indicating greater sense of safety.
This is designed to gauge how safe patients feel visiting the clinic in-person vs. online via telemedicine during the COVID pandemic
|
7 to 14 days postoperatively
|
|
Length of visit
Time Frame: 7 to 14 days postoperatively
|
Length of postoperative visit
|
7 to 14 days postoperatively
|
|
Patient willingness to recommend provider to peers rated from 1 to 5
Time Frame: 7 to 14 days postoperatively
|
Patient willingness to recommend provider to peers rated from 1 to 5
|
7 to 14 days postoperatively
|
|
Combined patient satisfaction score from 1st and 2nd postoperative visits
Time Frame: 7 to 31 days postoperatively
|
Combined patient satisfaction score from 1st and 2nd postoperative visits
|
7 to 31 days postoperatively
|
|
Distance (in kilometers) of patient's primary residence to the clinic location
Time Frame: 7 to 31 days postoperatively
|
Distance (in kilometers) of patient's primary residence to the clinic location
|
7 to 31 days postoperatively
|
|
60-day rate of hospital readmission
Time Frame: 60 days postoperatively
|
Incidence of hospital readmission 60 days postoperatively
|
60 days postoperatively
|
|
60-day rate of re-operation
Time Frame: 60 days postoperatively
|
Incidence of re-operation 60 days postoperatively
|
60 days postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karen Zaghiyan, MD, Associate Professor of Surgery
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: Evidence from the field. J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135. doi: 10.1093/jamia/ocaa072.
- Grenda TR, Whang S, Evans NR 3rd. Transitioning a Surgery Practice to Telehealth During COVID-19. Ann Surg. 2020 Aug;272(2):e168-e169. doi: 10.1097/SLA.0000000000004008.
- Gunter RL, Chouinard S, Fernandes-Taylor S, Wiseman JT, Clarkson S, Bennett K, Greenberg CC, Kent KC. Current Use of Telemedicine for Post-Discharge Surgical Care: A Systematic Review. J Am Coll Surg. 2016 May;222(5):915-27. doi: 10.1016/j.jamcollsurg.2016.01.062. Epub 2016 Feb 13. No abstract available.
- Huang EY, Knight S, Guetter CR, Davis CH, Moller M, Slama E, Crandall M. Telemedicine and telementoring in the surgical specialties: A narrative review. Am J Surg. 2019 Oct;218(4):760-766. doi: 10.1016/j.amjsurg.2019.07.018. Epub 2019 Jul 18.
- Hakim AA, Kellish AS, Atabek U, Spitz FR, Hong YK. Implications for the use of telehealth in surgical patients during the COVID-19 pandemic. Am J Surg. 2020 Jul;220(1):48-49. doi: 10.1016/j.amjsurg.2020.04.026. Epub 2020 Apr 21.
- Hwa K, Wren SM. Telehealth follow-up in lieu of postoperative clinic visit for ambulatory surgery: results of a pilot program. JAMA Surg. 2013 Sep;148(9):823-7. doi: 10.1001/jamasurg.2013.2672.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 28, 2020
Primary Completion (Actual)
June 30, 2022
Study Completion (Actual)
June 30, 2022
Study Registration Dates
First Submitted
December 2, 2020
First Submitted That Met QC Criteria
December 2, 2020
First Posted (Actual)
December 3, 2020
Study Record Updates
Last Update Posted (Estimate)
December 26, 2022
Last Update Submitted That Met QC Criteria
December 22, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00000944
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on Telemedicine visit
-
Wake Forest University Health SciencesWithdrawnFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma
-
NYU Langone HealthCompletedEnd Stage Renal Disease | Kidney Disease, ChronicUnited States
-
Texas Tech University Health Sciences Center, El...CompletedLaparoscopic Gynecologic SurgeryUnited States
-
Vanderbilt University Medical CenterAllergan FoundationCompletedTelemedicine | Cervical DystoniaUnited States
-
University of RochesterDavis Phinney FoundationCompleted
-
University of Alabama at BirminghamCompletedChronic Obstructive Pulmonary Disease | Chronic Heart FailureUnited States
-
Arizona State UniversityTerminatedHealth Service Research on TelemedicineUnited States
-
Vanderbilt UniversityNational Institute on Aging (NIA); Ohio State UniversityRecruitingPost-intensive Care SyndromeUnited States
-
The Hawkins FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Prostate Cancer | Patient Engagement | Patient Satisfaction | Patient PreferenceUnited States